{"id":38102,"date":"2025-07-29T14:08:44","date_gmt":"2025-07-29T06:08:44","guid":{"rendered":"https:\/\/flcube.com\/?p=38102"},"modified":"2025-07-29T14:08:45","modified_gmt":"2025-07-29T06:08:45","slug":"tigermed-acquires-japans-micron-cro-to-expand-imaging-expertise-in-asia-pacific","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=38102","title":{"rendered":"Tigermed Acquires Japan’s Micron CRO to Expand Imaging Expertise in Asia-Pacific"},"content":{"rendered":"\n

China-based Tigermed (SHE: 300347<\/a>, HKG: 3347<\/a>) announced on July 29, 2025, that it has completed the acquisition of Micron, a leading Contract Research Organization (CRO) based in Japan. This strategic move underscores Tigermed’s commitment to expanding its clinical research capabilities in the Asia-Pacific region.<\/p>\n\n\n\n

Micron’s Expertise and Achievements<\/strong>
Founded in 2005 and headquartered in Tokyo, Micron is renowned for its extensive team of medical imaging experts, one of the largest in Asia. Specializing in imaging analysis and clinical trial services, Micron has served over 250 clients and supported the market launch of more than 40 products. As Japan’s first CRO dedicated to imaging analysis, Micron has made significant strides in areas such as imaging biomarkers and AI-aided imaging. In 2024, Micron was honored with the “Best Contract Research Organization in All Japan Award.”<\/p>\n\n\n\n

Post-Acquisition Vision<\/strong>
Post-acquisition, Micron will integrate into Tigermed’s operations in Japan, becoming a pivotal component of its service offerings. This integration is poised to elevate Tigermed’s client coverage and service capabilities across Japan and the broader Asia-Pacific region.-Fineline Info & Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

China-based Tigermed (SHE: 300347, HKG: 3347) announced on July 29, 2025, that it has completed…<\/p>\n","protected":false},"author":1,"featured_media":38106,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[949,4252,948,244],"class_list":["post-38102","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-hkg-3347","tag-micron","tag-she-300347","tag-tigermed"],"yoast_head":"\nTigermed Acquires Japan's Micron CRO to Expand Imaging Expertise in Asia-Pacific - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China-based Tigermed (SHE: 300347, HKG: 3347) announced on July 29, 2025, that it has completed the acquisition of Micron, a leading Contract Research Organization (CRO) based in Japan. This strategic move underscores Tigermed's commitment to expanding its clinical research capabilities in the Asia-Pacific region.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=38102\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tigermed Acquires Japan's Micron CRO to Expand Imaging Expertise in Asia-Pacific\" \/>\n<meta property=\"og:description\" content=\"China-based Tigermed (SHE: 300347, HKG: 3347) announced on July 29, 2025, that it has completed the acquisition of Micron, a leading Contract Research Organization (CRO) based in Japan. This strategic move underscores Tigermed's commitment to expanding its clinical research capabilities in the Asia-Pacific region.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=38102\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-29T06:08:44+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-29T06:08:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/2908.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38102#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38102\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Tigermed Acquires Japan’s Micron CRO to Expand Imaging Expertise in Asia-Pacific\",\"datePublished\":\"2025-07-29T06:08:44+00:00\",\"dateModified\":\"2025-07-29T06:08:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38102\"},\"wordCount\":184,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38102#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/2908.webp\",\"keywords\":[\"HKG: 3347\",\"Micron\",\"SHE: 300347\",\"Tigermed\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=38102#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38102\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=38102\",\"name\":\"Tigermed Acquires Japan's Micron CRO to Expand Imaging Expertise in Asia-Pacific - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38102#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38102#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/2908.webp\",\"datePublished\":\"2025-07-29T06:08:44+00:00\",\"dateModified\":\"2025-07-29T06:08:45+00:00\",\"description\":\"China-based Tigermed (SHE: 300347, HKG: 3347) announced on July 29, 2025, that it has completed the acquisition of Micron, a leading Contract Research Organization (CRO) based in Japan. This strategic move underscores Tigermed's commitment to expanding its clinical research capabilities in the Asia-Pacific region.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38102#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=38102\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38102#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/2908.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/2908.webp\",\"width\":1080,\"height\":608,\"caption\":\"Tigermed Acquires Japan's Micron CRO to Expand Imaging Expertise in Asia-Pacific\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38102#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tigermed Acquires Japan’s Micron CRO to Expand Imaging Expertise in Asia-Pacific\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Tigermed Acquires Japan's Micron CRO to Expand Imaging Expertise in Asia-Pacific - Insight, China's Pharmaceutical Industry","description":"China-based Tigermed (SHE: 300347, HKG: 3347) announced on July 29, 2025, that it has completed the acquisition of Micron, a leading Contract Research Organization (CRO) based in Japan. This strategic move underscores Tigermed's commitment to expanding its clinical research capabilities in the Asia-Pacific region.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=38102","og_locale":"en_US","og_type":"article","og_title":"Tigermed Acquires Japan's Micron CRO to Expand Imaging Expertise in Asia-Pacific","og_description":"China-based Tigermed (SHE: 300347, HKG: 3347) announced on July 29, 2025, that it has completed the acquisition of Micron, a leading Contract Research Organization (CRO) based in Japan. This strategic move underscores Tigermed's commitment to expanding its clinical research capabilities in the Asia-Pacific region.","og_url":"https:\/\/flcube.com\/?p=38102","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-07-29T06:08:44+00:00","article_modified_time":"2025-07-29T06:08:45+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/2908.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=38102#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=38102"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Tigermed Acquires Japan’s Micron CRO to Expand Imaging Expertise in Asia-Pacific","datePublished":"2025-07-29T06:08:44+00:00","dateModified":"2025-07-29T06:08:45+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=38102"},"wordCount":184,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=38102#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/2908.webp","keywords":["HKG: 3347","Micron","SHE: 300347","Tigermed"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=38102#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=38102","url":"https:\/\/flcube.com\/?p=38102","name":"Tigermed Acquires Japan's Micron CRO to Expand Imaging Expertise in Asia-Pacific - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=38102#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=38102#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/2908.webp","datePublished":"2025-07-29T06:08:44+00:00","dateModified":"2025-07-29T06:08:45+00:00","description":"China-based Tigermed (SHE: 300347, HKG: 3347) announced on July 29, 2025, that it has completed the acquisition of Micron, a leading Contract Research Organization (CRO) based in Japan. This strategic move underscores Tigermed's commitment to expanding its clinical research capabilities in the Asia-Pacific region.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=38102#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=38102"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=38102#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/2908.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/2908.webp","width":1080,"height":608,"caption":"Tigermed Acquires Japan's Micron CRO to Expand Imaging Expertise in Asia-Pacific"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=38102#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Tigermed Acquires Japan’s Micron CRO to Expand Imaging Expertise in Asia-Pacific"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/2908.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/38102","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=38102"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/38102\/revisions"}],"predecessor-version":[{"id":38107,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/38102\/revisions\/38107"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/38106"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=38102"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=38102"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=38102"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}